Hilbe W - Search Results

1

Identification of a favorable subgroup of patients with generalized immunocytomas by follicular dendritic cells.

Eisterer W, Hilbe W, Fend F, Ludescher C, Falk M, Thaler J. Eisterer W, et al. Among authors: hilbe w. Leukemia. 1995 Feb;9(2):254-9. Leukemia. 1995. PMID: 7869760

2

Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.

Ludescher C, Eisterer W, Hilbe W, Gotwald M, Hofmann J, Zabernigg A, Cianfriglia M, Thaler J. Ludescher C, et al. Among authors: hilbe w. Leukemia. 1995 Feb;9(2):350-6. Leukemia. 1995. PMID: 7869774

3

Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16).

Hilbe W, Thaler J, Eisterer W, Ludescher C, Niederwieser D. Hilbe W, et al. Leuk Res. 1994 Sep;18(9):655-8. doi: 10.1016/0145-2126(94)90063-9. Leuk Res. 1994. PMID: 7934139 Clinical Trial.

4

Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.

Hilbe W, Apfelbeck U, Fridrik M, Bernhart M, Niessner H, Abbrederis K, Michlmayr G, Pont J, Linkesch W, Hausmaninger H, Arneitz K, Baldinger C, Duba C, Eisterer W, Greil R, Konwalinka G, Niederwieser D, Gastl G, Thaler J. Hilbe W, et al. Leuk Res. 1998 Oct;22(10):881-6. doi: 10.1016/s0145-2126(98)00064-2. Leuk Res. 1998. PMID: 9766747

5

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma.

Eisterer W, Bechter O, Hilbe W, van Driel M, Lokhorst HM, Thaler J, Bloem AC, Günthert U, Stauder R. Eisterer W, et al. Among authors: hilbe w. Leuk Res. 2001 Dec;25(12):1051-7. doi: 10.1016/s0145-2126(01)00075-3. Leuk Res. 2001. PMID: 11684276

6

[Functional detection of P-glycoprotein expressing cells with flow cytometry].

Ludescher C, Hilbe W, Eisterer W, Preuss E, Hofmann J, Thaler J. Ludescher C, et al. Among authors: hilbe w. Wien Klin Wochenschr. 1994;106(8):242-6. Wien Klin Wochenschr. 1994. PMID: 7912868 German.

7

Bone marrow lymphocyte subsets in myelodysplastic syndromes.

Hilbe W, Eisterer W, Schmid C, Starz I, Silly H, Duba C, Ludescher C, Thaler J. Hilbe W, et al. J Clin Pathol. 1994 Jun;47(6):505-7. doi: 10.1136/jcp.47.6.505. J Clin Pathol. 1994. PMID: 8063930 Free PMC article.

8

Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.

Ludescher C, Hilbe W, Eisterer W, Preuss E, Huber C, Gotwald M, Hofmann J, Thaler J. Ludescher C, et al. Among authors: hilbe w. J Natl Cancer Inst. 1993 Nov 3;85(21):1751-8. doi: 10.1093/jnci/85.21.1751. J Natl Cancer Inst. 1993. PMID: 8105101

9

Decreased potency of MDR-modulators under serum conditions determined by a functional assay.

Ludescher C, Eisterer W, Hilbe W, Hofmann J, Thaler J. Ludescher C, et al. Among authors: hilbe w. Br J Haematol. 1995 Nov;91(3):652-7. doi: 10.1111/j.1365-2141.1995.tb05362.x. Br J Haematol. 1995. PMID: 8555069

10

An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c.

Eistere W, Hilbe W, Stauder R, Bechter O, Fend F, Thaler J. Eistere W, et al. Among authors: hilbe w. Br J Haematol. 1996 Jun;93(3):661-9. doi: 10.1046/j.1365-2141.1996.d01-1704.x. Br J Haematol. 1996. PMID: 8652389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters